LTTA :: News

Festival della Cultura Tecnica

Che effetti ha la dieta sull'insorgenza di malattie cardiovascolari e tumori? In che modo è possibile prevenire la diffusione del COVID19?
Queste ed altre domande saranno trattate nel corso del Festival della Cultura Tecnica, presso l’ex teatro Verdi - Laboratori aperti di Ferrara da parte dei ricercatori dei laboratori LTTA e Terra&Acqua Tech.
Il 24 novembre si terrà il primo incontro il primo incontro “La medicina tra presente e futuro: in che direzione ci stiamo muovendo?”, durante il quale si illustreranno le attività dei ricercatori del Laboratorio per le Tecnologie delle Terapie Avanzate nell'ambito della medicina Preventiva, Predittiva, Personalizzata e Partecipativa.
Maggiori informazioni sono sul sito del Tecnopolo di Ferrara .

L'evento è solo in presenza ed è gradita l'iscrizione entro Martedì 23 Nov ore 12:00 tramite form https://bit.ly/3CqKILz.
Il laboratorio LTTA vi aspetta tra i partecipanti e vi prega di dare massima diffusione alle iniziative.
L'accesso è possibile previo controllo del green pass.

Lacricomplex: Ophthalmic Medical Device based on GlicoPro®

The Spin-Off HelixPharma srl of the University of Ferrara, in partnership with FB Vision Spa (San Benedetto del Tronto; Italy) placed on market "Lacricomplex". The first ophthalmic solution used to treat the dry eye syndrome (DES) thanks to the patented and highly innovative ingredient: GlicoPro®.
The chemical and biological properties of GlicoPro® were verified through a validated scientific method by LTTA (Technological Laboratory for Advanced Therapy) specialists, Professor Roberta Rizzo and Professor Claudio Trapella.
Further information can be found using the following link

The level 3 biosafety laboratory (BSL3) is active for studies on COVID-19

Starting from 01/09/2020 the University of Ferrara will make available the level 3 biosafety laboratory (BSL3) for studies on COVID-19. The laboratory provides services for the determination of the antiviral activity of biological or chemical compounds, the determination of the presence of SARS-CoV-2 RNA in biological and environmental samples, the execution and design of research protocols. For more information or consultancy, contact Prof. Roberta Rizzo, Clinical Research Service, LTTA and Head of the BSL3 laboratory; roberta.rizzo@unife.it, 0532 455382.

Antioxidant and immune-boosting activity of Papaya fermented with probiotics

Studies conducted by LTTA have shown that Papaya fermented with probiotics has an antioxidant and immune system strengthening activity, confirming the nutraceutical value of this vegetable. The results obtained (patent pending) led to the production of the food supplement Papaya Fermented by La Farmacia delle Erbe. More information on the methodologies used and possible applications in other areas are available at the following link .

Highly stable super-drugs

In a recent study published in the prestigious Journal Science Translational Medicine, a new, highly stable engineered anti-hemorrhagic molecule is described. This ability is of great importance for coagulation- related diseases, as it could translate into a greater therapeutic window allowing a reduction in the number of injections, with a consequent improvement in the quality of life of the patients treated. The study, conducted by Dr. Alessio Branchini and Prof. Mirko Pinotti of LTTA in collaboration with an international research team with expertise in immunology, biochemistry and coagulation diseases, is reported at the link: An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics . In particular, the drug combines the characteristics of coagulation factor VII, useful for preventing / stopping bleeding, with those of albumin, a protein that naturally circulates in our blood and which is highly stable. The combination of the two characteristics gives the engineered factor, that is the drug, the ability to be effective in the blood for longer time, in comparison to existing treatments.